4//SEC Filing
Regulus Therapeutics Inc. 4
Accession 0001209191-14-064295
CIK 0001505512operating
Filed
Oct 21, 8:00 PM ET
Accepted
Oct 22, 4:11 PM ET
Size
6.0 KB
Accession
0001209191-14-064295
Insider Transaction Report
Form 4
GRINT PAUL C
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2014-10-20+40,000→ 40,000 totalExercise: $7.58Exp: 2024-06-15→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]On June 16, 2014, the reporting person was granted an option to purchase 100,000 shares of common stock which vest upon achievement of certain performance criteria: 40% of the shares commence vesting upon achievement of the first goal, 30% of the shares commence vesting upon achievement of the second goal and 30% of the shares commence vesting upon achievement of the third goal, in each case, upon achievement of each goal, 50% of the shares shall immediately vest and the remaining shares shall vest in equal monthly installments over the two years following the vesting commencement date. On October 20, 2014 performance criteria for the first goal were met, resulting in the commencement of vesting of 40,000 shares.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001505512
Filing Metadata
- Form type
- 4
- Filed
- Oct 21, 8:00 PM ET
- Accepted
- Oct 22, 4:11 PM ET
- Size
- 6.0 KB